Epicardial adipose tissue volume is not an independent predictor of atrial fibrillation recurrence after catheter ablation

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Francisca Almeida Saraiva

    Autor

  • António Sousa Barros

    Autor

  • Francisco Pedro Morais Dias De Almeida Sampaio

    Autor

  • Ricardo José Araújo Ladeiras Lopes

    Autor

  • Ricardo Manuel Alves Monteiro Fontes De Carvalho

    Autor

Participantes de fora da FMUP

  • Cruz, I
  • Fernandes, SL
  • Diaz, SO
  • Primo, J

Unidades de investigação

Abstract

Introduction and objectives: Previous studies have suggested that epicardial adipose tissue (EAT) could exert a paracrine effect in the myocardium. However, few studies have assessed its role in the risk of atrial fibrillation (AF) recurrence. This study aimed to evaluate the association between EAT volume, and its attenuation, with the risk of AF recurrence after AF ablation. Methods: A total of 350 consecutive patients who underwent AF ablation were included. The median age was 57 [IQR 48-65] years and 21% had persistent AF. Epicardial fat was quantified by multidetector computed tomography using Syngo. via Frontier-Cardiac Risk Assessment software, measuring pericardial fat volume (PATV), EAT volume, and attenuation of EAT posterior to the left atrium. AF recurrence was defined as any documented episode of AF, atrial flutter, or atrial tachycardia more than 3 months after the procedure. Results: After a median follow-up of 34 [range, 12-57] months, 114 patients (33%) had AF recurrence. Univariable Cox regression showed that patients with an EAT volume >= 80 mL had an increased risk of AF recurrence (HR, 1.65; 95%CI, 1.14-2.39; P =.007). However, after multivariable adjustment, EAT volume did not remain an independent predictor of AF recurrence (HR, 1.24; 95%CI, 0.83-1.87; P =.3). Similar results were observed with PATV. Patients with lower attenuation of EAT did not have a higher risk of AF recurrence (log-rank test, P =.75). Conclusions: EAT parameters including the evaluation of EAT volume, PATV and EAT attenuation were not independent predictors of AF recurrence after catheter ablation. (c) C 2022 Sociedad Espanola de Cardiologi ' a. Published by Elsevier Espana, S.L.U. All rights reserved.

Dados da publicação

ISSN/ISSNe:
1885-5857, 1579-2242

REVISTA ESPANOLA DE CARDIOLOGIA  Elsevier Doyma

Tipo:
Article
Páginas:
539-547

Citações Recebidas na Web of Science: 1

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • Atrial fibrillation; Epicardial adipose tissue; Computed tomography; Catheter ablation

Financiamento

Proyectos asociados

Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684

Investigador Principal: João Pedro Melo Marques Pinho Ferreira

Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022

Screening of Fabry Disease in Portuguese Patients With Idiopathic Cardiomyopathies (F-CHECK) - NCT05409846

Investigador Principal: Elisabete Lousada Martins Oliveira Bernardes

Estudo Observacional Académico (F-CHECK) . Sanofi . 2022

The Impact of Obesity on Cardiac Function and Morphology in Aortic Stenosis

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico (Obesity) . 2020

Suboptimal control of cardiovascular risk factors in myocardial infarction survivors

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico (myocard) . 2020

Impacto dos acessos femorais guiados por ecografia vs fluoroscopia nas complicações vasculares associadas à implantação de válvula aórtica percutânea

Investigador Principal: Francisco Pedro Morais Dias de Almeida Sampaio

Estudo Clínico Académico . 2021

Modeling Aortic Stenosis progression: impact on follow-up, treatment, and survival

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico . 2022

Epicardial adipose tissue volume is not an independent predictor of atrial fibrillation recurrence after ablation

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico . 2022

Social Media Use by Cardiovascular Healthcare Professionals in Portugal

Investigador Principal: Ricardo José Araújo Ladeiras Lopes

Estudo Clínico Académico (Cardiovascular Healthca) . 2022

Flow-status in severe aortic stenosis for percutaneous valve implantation: Should we follow the flow?

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico . 2022

Cardiovascular Impact of Metabolic Syndrome: From Mechanisms to New Treatment Targets

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico . 2021

Citar a publicação

Partilhar a publicação